Skip to main content
Top
Published in: Internal and Emergency Medicine 2/2010

01-04-2010 | IM - Original

Carotid intima-media thickness and bone turnover: the role of C-terminal telopeptide of type I collagen

Authors: Christian Leli, Leonella Pasqualini, Gaetano Vaudo, Stefano Gaggioli, Anna Maria Scarponi, Elmo Mannarino

Published in: Internal and Emergency Medicine | Issue 2/2010

Login to get access

Abstract

Osteoporosis and vascular disease are commonly found together in elderly people. Several common mechanisms and risk factors have been suggested to contribute to the development of osteoporosis and atherosclerosis. The present cross-sectional study was performed to determine whether the degree of bone turnover is correlated to carotid intima-media thickness (CCA-IMT), as a marker of subclinical atherosclerosis. We selected 50 outpatients (mean age 71.7 ± 12.3), underwent to eco-Doppler evaluation of extracranial carotid tract, without history of calcium and/or vitamin D supplementation, or antireabsorptive therapy. CCA-IMT was measured by high-resolution B-mode ultrasonography. Bone turnover was evaluated by analysing serum levels of C-terminal telopeptide of type I collagen (sCTX), and bone-specific alkaline phosphatase. We also evaluated the vitamin D status by determination of the serum concentration of 25-hydroxyvitamin D [25(OH)D]. We found a prevalence of hypovitaminosis D [serum 25(OH)D levels <30 ng/mL, mean value 10.7 ± 5.8] of 91.8%, and an increased bone resorption, with mean sCTX levels higher than reference values (mean 1.18 ± 0.57 ng/mL). A significant positive correlation was found between CCA-IMT and age (r = 0.480, P = 0.001), erythrocyte sedimentation rate (ESR: r = 0.438, P = 0.001), high-sensitivity C-Reactive Protein (HsCRP: r = 0.482, P = 0.011), serum creatinine (r = 0.305, P = 0.031), and sCTX (r = 0.389, P = 0.006). In a multivariate linear regression, CCA-IMT was independently predicted by age (β = 0.34, P = 0.001), ESR (β = 0.37, P = 0.005), and sCTX (β = 0.32, P = 0.006). The preliminary results of our study seem to indicate that after adjustment for established cardiovascular risk factors, sCTX independently predict an increased CCA-IMT in the elderly population.
Literature
1.
go back to reference Naves M, Rodríguez-García M, Díaz-López JB et al (2008) Progression of vascular calcifications associated with greater bone loss and increased bone fractures. Osteoporos Int 19:1161–1166CrossRefPubMed Naves M, Rodríguez-García M, Díaz-López JB et al (2008) Progression of vascular calcifications associated with greater bone loss and increased bone fractures. Osteoporos Int 19:1161–1166CrossRefPubMed
2.
go back to reference Szulc P, Kiel DP, Delmas PD (2008) Calcifications in the abdominal aorta predict fractures in men: MINOS study. J Bone Miner Res 23:95–102CrossRefPubMed Szulc P, Kiel DP, Delmas PD (2008) Calcifications in the abdominal aorta predict fractures in men: MINOS study. J Bone Miner Res 23:95–102CrossRefPubMed
3.
go back to reference de Groot E, van Leuven SI, Duivenvoorden R et al (2008) Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis. Nat Clin Pract Cardiovasc Med 5:280–288CrossRefPubMed de Groot E, van Leuven SI, Duivenvoorden R et al (2008) Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis. Nat Clin Pract Cardiovasc Med 5:280–288CrossRefPubMed
4.
go back to reference Sumino H, Ichikawa S, Kasama S et al (2008) Relationship between carotid atherosclerosis and lumbar spine bone mineral density in postmenopausal women. Hypertens Res 31:1191–1197CrossRefPubMed Sumino H, Ichikawa S, Kasama S et al (2008) Relationship between carotid atherosclerosis and lumbar spine bone mineral density in postmenopausal women. Hypertens Res 31:1191–1197CrossRefPubMed
5.
go back to reference Tekin GO, Kekilli E, Yagmur J et al (2008) Evaluation of cardiovascular risk factors and bone mineral density in post menopausal women undergoing coronary angiography. Int J Cardiol 131:66–69CrossRefPubMed Tekin GO, Kekilli E, Yagmur J et al (2008) Evaluation of cardiovascular risk factors and bone mineral density in post menopausal women undergoing coronary angiography. Int J Cardiol 131:66–69CrossRefPubMed
6.
go back to reference Shanahan CM (2005) Mechanisms of vascular calcification in renal disease. Clin Nephrol 63:146–157PubMed Shanahan CM (2005) Mechanisms of vascular calcification in renal disease. Clin Nephrol 63:146–157PubMed
7.
go back to reference Demer LL (2002) Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids. Int J Epidemiol 31:737–741CrossRefPubMed Demer LL (2002) Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids. Int J Epidemiol 31:737–741CrossRefPubMed
8.
go back to reference Michos ED, Melamed ML (2008) Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care 11:7–12CrossRefPubMed Michos ED, Melamed ML (2008) Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care 11:7–12CrossRefPubMed
9.
go back to reference Hofbauer LC, Brueck CC, Shanahan CM et al (2007) Vascular calcification and osteoporosis-from clinical observation towards molecular understanding. Osteoporos Int 18:251–259CrossRefPubMed Hofbauer LC, Brueck CC, Shanahan CM et al (2007) Vascular calcification and osteoporosis-from clinical observation towards molecular understanding. Osteoporos Int 18:251–259CrossRefPubMed
10.
go back to reference Garnero P (2008) Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring. Mol Diagn Ther 12:157–170PubMed Garnero P (2008) Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring. Mol Diagn Ther 12:157–170PubMed
11.
go back to reference Okabe R, Inaba M, Nakatsuka K et al (2004) Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline. J Bone Miner Metab 22:127–131CrossRefPubMed Okabe R, Inaba M, Nakatsuka K et al (2004) Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline. J Bone Miner Metab 22:127–131CrossRefPubMed
12.
go back to reference Garnero P, Hausherr E, Chapuy MC et al (1996) Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res 11:1531–1538CrossRefPubMed Garnero P, Hausherr E, Chapuy MC et al (1996) Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res 11:1531–1538CrossRefPubMed
13.
go back to reference Brown JP, Josse RG (2002) Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 12:S1–S34 Brown JP, Josse RG (2002) Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 12:S1–S34
14.
go back to reference Cifkova R, Erdine S, Fagard R et al (2003) ESH/ESC Hypertension Guidelines Committee. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 21:1779–1786CrossRefPubMed Cifkova R, Erdine S, Fagard R et al (2003) ESH/ESC Hypertension Guidelines Committee. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 21:1779–1786CrossRefPubMed
15.
go back to reference American Diabetes Association (2008) Diagnosis and classification of diabetes mellitus. Diabetes Care 31:S55–S60 American Diabetes Association (2008) Diagnosis and classification of diabetes mellitus. Diabetes Care 31:S55–S60
16.
go back to reference Adult Treatment Panel III (2002) Final report. Circulation 106:3143–3421 Adult Treatment Panel III (2002) Final report. Circulation 106:3143–3421
17.
go back to reference Hollis BW (2008) Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. Curr Opin Endocrinol Diabetes Obes 15:489–494PubMed Hollis BW (2008) Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. Curr Opin Endocrinol Diabetes Obes 15:489–494PubMed
18.
go back to reference Lorenz MW, Markus HS, Bots ML et al (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115:459–467CrossRefPubMed Lorenz MW, Markus HS, Bots ML et al (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115:459–467CrossRefPubMed
19.
go back to reference Tamaki J, Iki M, Hirano Y et al (2009) Low bone mass is associated with carotid atherosclerosis in postmenopausal women: the Japanese population-based osteoporosis (JPOS) cohort study. Osteoporos Int 20:53–60CrossRefPubMed Tamaki J, Iki M, Hirano Y et al (2009) Low bone mass is associated with carotid atherosclerosis in postmenopausal women: the Japanese population-based osteoporosis (JPOS) cohort study. Osteoporos Int 20:53–60CrossRefPubMed
20.
go back to reference Trento LK, Pietropolli A, Ticconi C et al (2009) Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women. J Obstet Gynaecol Res 35:152–159CrossRefPubMed Trento LK, Pietropolli A, Ticconi C et al (2009) Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women. J Obstet Gynaecol Res 35:152–159CrossRefPubMed
21.
go back to reference Choi HJ, Im JA, Kim SH (2008) Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss. Maturitas 60:170–176CrossRefPubMed Choi HJ, Im JA, Kim SH (2008) Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss. Maturitas 60:170–176CrossRefPubMed
22.
go back to reference Binkley N, Silverman SL, Simonelli C et al (2009) Monthly ibandronate suppresses serum CTX-I within 3 days and maintains a monthly fluctuating pattern of suppression. Osteoporos Int (Jan 15) Binkley N, Silverman SL, Simonelli C et al (2009) Monthly ibandronate suppresses serum CTX-I within 3 days and maintains a monthly fluctuating pattern of suppression. Osteoporos Int (Jan 15)
23.
go back to reference Siepi D, Marchesi S, Vaudo G et al (2008) Preclinical vascular damage in white postmenopausal women: the relevance of osteoprotegerin. Metabolism 57:321–325CrossRefPubMed Siepi D, Marchesi S, Vaudo G et al (2008) Preclinical vascular damage in white postmenopausal women: the relevance of osteoprotegerin. Metabolism 57:321–325CrossRefPubMed
24.
go back to reference Erdogan B, Aslan E, Bagis T et al (2004) Intima-media thickness of the carotid arteries is related to serum osteoprotegerin levels in healthy postmenopausal women. Neurol Res 26:658–661CrossRefPubMed Erdogan B, Aslan E, Bagis T et al (2004) Intima-media thickness of the carotid arteries is related to serum osteoprotegerin levels in healthy postmenopausal women. Neurol Res 26:658–661CrossRefPubMed
25.
go back to reference Nagata-Sakurai M, Inaba M, Goto H et al (2003) Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis. Arthritis Rheum 48:3061–3067CrossRefPubMed Nagata-Sakurai M, Inaba M, Goto H et al (2003) Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis. Arthritis Rheum 48:3061–3067CrossRefPubMed
26.
go back to reference Shioi A, Katagi M, Okuno Y et al (2002) Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ Res 91:9–16CrossRefPubMed Shioi A, Katagi M, Okuno Y et al (2002) Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ Res 91:9–16CrossRefPubMed
27.
go back to reference Dhore CR, Cleutjens JP, Lutgens E et al (2001) Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 21:1998–2003CrossRefPubMed Dhore CR, Cleutjens JP, Lutgens E et al (2001) Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 21:1998–2003CrossRefPubMed
28.
go back to reference Boström K, Watson KE, Horn S et al (1993) Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 91:1800–1809CrossRefPubMed Boström K, Watson KE, Horn S et al (1993) Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 91:1800–1809CrossRefPubMed
29.
go back to reference Shanahan CM, Cary NR, Metcalfe JC et al (1994) High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 93:2393–2402CrossRefPubMed Shanahan CM, Cary NR, Metcalfe JC et al (1994) High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 93:2393–2402CrossRefPubMed
30.
go back to reference Massey HM, Flanagan AM (1999) Human osteoclasts derive from CD14- positive monocytes. Br J Haematol 106:167–170CrossRefPubMed Massey HM, Flanagan AM (1999) Human osteoclasts derive from CD14- positive monocytes. Br J Haematol 106:167–170CrossRefPubMed
31.
go back to reference Udagawa N, Takahashi N, Akatsu T et al (1990) Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA 87:7260–7264CrossRefPubMed Udagawa N, Takahashi N, Akatsu T et al (1990) Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA 87:7260–7264CrossRefPubMed
32.
go back to reference Busti C, Falcinelli E, Momi S et al (2009) Matrix metalloproteinases and peripheral arterial disease. Intern Emerg Med (Sep 24) Busti C, Falcinelli E, Momi S et al (2009) Matrix metalloproteinases and peripheral arterial disease. Intern Emerg Med (Sep 24)
33.
go back to reference Luo XH, Guo LJ, Shan PF et al (2006) Relationship of circulating MMP-2, MMP-1, and TIMP-1 levels with bone biochemical markers and bone mineral density in postmenopausal Chinese women. Osteoporos Int 17:521–526CrossRefPubMed Luo XH, Guo LJ, Shan PF et al (2006) Relationship of circulating MMP-2, MMP-1, and TIMP-1 levels with bone biochemical markers and bone mineral density in postmenopausal Chinese women. Osteoporos Int 17:521–526CrossRefPubMed
34.
go back to reference Pennisi P, Signorelli SS, Riccobene S et al (2004) Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporos Int 15:389–395CrossRefPubMed Pennisi P, Signorelli SS, Riccobene S et al (2004) Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporos Int 15:389–395CrossRefPubMed
35.
go back to reference Herrmann M, Seibel MJ (2008) The amino- and carboxyterminal cross-linked telopeptides of collagen type I, NTX-I and CTX-I: a comparative review. Clin Chim Acta 393:57–75CrossRefPubMed Herrmann M, Seibel MJ (2008) The amino- and carboxyterminal cross-linked telopeptides of collagen type I, NTX-I and CTX-I: a comparative review. Clin Chim Acta 393:57–75CrossRefPubMed
36.
go back to reference Linnebur SA, Vondracek SF, van de Griend JP et al (2007) Prevalence of vitamin D insufficiency in elderly ambulatory outpatients in Denver, Colorado. Am J Geriatr Pharmacother 5:1–8 Linnebur SA, Vondracek SF, van de Griend JP et al (2007) Prevalence of vitamin D insufficiency in elderly ambulatory outpatients in Denver, Colorado. Am J Geriatr Pharmacother 5:1–8
37.
go back to reference Watson KE, Abrolat ML, Malone LL et al (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96:1755–1760PubMed Watson KE, Abrolat ML, Malone LL et al (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96:1755–1760PubMed
38.
go back to reference Scragg R, Jackson R, Holdaway IM et al (1990) Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 19:559–563CrossRefPubMed Scragg R, Jackson R, Holdaway IM et al (1990) Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 19:559–563CrossRefPubMed
39.
go back to reference Poole KE, Loveridge N, Barker PJ et al (2006) Reduced vitamin D in acute stroke. Stroke 37:243–245CrossRefPubMed Poole KE, Loveridge N, Barker PJ et al (2006) Reduced vitamin D in acute stroke. Stroke 37:243–245CrossRefPubMed
40.
go back to reference Delmas PD, Eastell R, Garnero P et al (2000) The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 6:S2–S17CrossRef Delmas PD, Eastell R, Garnero P et al (2000) The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 6:S2–S17CrossRef
41.
go back to reference Budek AZ, Hoppe C, Michaelsen KF et al (2007) Associations of total, dairy, and meat protein with markers for bone turnover in healthy, prepubertal boys. J Nutr 137:930–934PubMed Budek AZ, Hoppe C, Michaelsen KF et al (2007) Associations of total, dairy, and meat protein with markers for bone turnover in healthy, prepubertal boys. J Nutr 137:930–934PubMed
Metadata
Title
Carotid intima-media thickness and bone turnover: the role of C-terminal telopeptide of type I collagen
Authors
Christian Leli
Leonella Pasqualini
Gaetano Vaudo
Stefano Gaggioli
Anna Maria Scarponi
Elmo Mannarino
Publication date
01-04-2010
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue 2/2010
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-010-0356-y

Other articles of this Issue 2/2010

Internal and Emergency Medicine 2/2010 Go to the issue

IM - Physical Examination

Searching for pale, getting rickets

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.